ASP7374: Phase III ongoing

Astellas and UMN Pharma said all subjects were vaccinated in an open-label, Japanese Phase III trial evaluating intramuscular ASP7374. The trial planned to enroll 55 healthy volunteers ages >=61 years. Both companies declined to disclose the number of subjects enrolled. ...